← Eichor
Condition: Mixed Connective Tissue Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mixed Connective Tissue Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Phase 1 · 31 location(s) · Therapeutic Advances in Childhood Leukemia Consortium · NCT05476770Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434The Florida ASCENT Study
NA · 1 location(s) · University of Florida · NCT07042243Fetal Cell Receptors Repertoire
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06031714Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975New Orleans Pulmonary Hypertension Biobank
Phase N/A · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT03269630ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05542407Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax,
Phase 1 · 44 location(s) · Kura Oncology, Inc. · NCT05735184Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
NA · 1 location(s) · Terry L. Wahls · NCT07180537Efficacy and Safety of Light Compression System in the Local Treatment of Mixed Leg Ulcers (PROMETHEE Clinical Investiga
NA · 3 location(s) · Laboratoires URGO · NCT06899919Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086International Rare Histiocytic Disorders Registry (IRHDR)
Phase N/A · 15 location(s) · The Hospital for Sick Children · NCT02285582International PPB/DICER1 Registry
Phase N/A · 1 location(s) · Children's Hospitals and Clinics of Minnesota · NCT03382158Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/Phase 2 · 12 location(s) · Milton S. Hershey Medical Center · NCT06465199Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms
Phase N/A · 3 location(s) · Swiss GO Trial Group · NCT07397715AVAVA MIRIA General Use
NA · 1 location(s) · AVAVA, Inc. · NCT06868615NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplast
Phase 1/Phase 2 · 28 location(s) · National Cancer Institute (NCI) · NCT04616560Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Perspectives on Antibiotics and Tracking Symptoms in Children
NA · 1 location(s) · Murdoch Childrens Research Institute · NCT07093749Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT07148050HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Ste
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03326921Pan-tumor MRD Study
Phase N/A · 2 location(s) · Paradigm Health · NCT06605404
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.